Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations

Cancer Research

Volumn 61, Issue 7, 2001, Pages 2974-2982

  Gee, M S ^a   Saunders, H M ^a   Lee, J C ^a   Sanzo, J F ^a   Jenkins, W T ^a   Evans, S M ^a   Trinchieri, G ^a   Sehgal, C M ^a   Feldman, M D ^a   Lee, W M F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

ANIMALS; CELL COUNT; CELL DIVISION; FEMALE; INTERLEUKIN-12; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MONITORING, PHYSIOLOGIC; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS;

EID: 0035300539     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. What is the evidence that tumors are angiogenesis dependent?
2. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
3. Angiostatin induces and sustains dormancy of human primary tumors in mice
4. Tumor development under angiogenic signaling: A dynamic theory of tumor growth, treatment response, and postvascular dormancy
5. Inhibitors of angiogenesis enter phase III testing
6. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
7. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
8. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients
9. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors
10. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
11. Determination of angiogenesis in human neoplasms: Current prognostic and therapeutic implications
12. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
13. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
14. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
15. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
16. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
17. Sonographic depiction of tumor vascularity and flow: From in vivo models to clinical applications
18. Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia
19. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
20. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
21. Quantified color Doppler sonography of tumor vascularity in an animal model
22. Quantitative vascularity of breast masses by Doppler Imaging: Regional variations and diagnostic implications
23. Evaluation of Doppler ultrasound for blood perfusion measurements
24. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US
25. Assessment of tumor vascularity in hepatocellular carcinoma: Comparison of power Doppler US and color Doppler US
26. Speculations on the role of ultraviolet radiation in the development of malignant melanoma
27. Biological behavior of malignant melanoma cells correlated to their survival in vivo
28. A murine renal cell carcinoma
29. Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
30. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12
31. Interleukin-12 inhibits angiogenesis induced by human tumor cell lines in vivo
32. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding
33. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
34. High-frequency color flow imaging of the microcirculation
35. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: Preliminary results
36. MR imaging of tumor microcirculation: Promise for the new millennium
37. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging